Clearance Summary
ENZA-O Titanium Lateral Anterior Lumbar Interbody Fusion (ALIF) received FDA 510(k) clearance under submission number K221324, sponsored by Camber Spine Technologies. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2023-03-30.
- Submission: K221324
- Applicant / Sponsor: Camber Spine Technologies
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3080
- Decision date: 2023-03-30
Classification & Regulation
This clearance is catalogued under FDA product code OVD and 21 CFR 888.3080, within the Orthopedic review panel as a Class II device.